| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.078 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |